Hepatic and Pancreatic manifestations of COVID-19
Background: Since its first detection in November 2019, the outbreak of severe acute respiratory syndrome coronavirus 2 has influenced over 200 countries, areas or territories worldwide. The virus was initially thought to be a primary respiratory pathogen, but has been reported to have multisystem i...
Main Authors: | Avinash H Rajanna, Vaibhav S Bellary, Arun Udayaraj |
---|---|
Format: | Article |
Language: | English |
Published: |
Manipal College of Medical Sciences, Pokhara
2022-06-01
|
Series: | Asian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://www.nepjol.info/index.php/AJMS/article/view/42810 |
Similar Items
-
Risk Stratification in Post-ERCP Pancreatitis: How Do Procedures, Patient Characteristics and Clinical Indicators Influence Outcomes?
by: Kapil Kohli, et al.
Published: (2021-02-01) -
Comparison of biochemical parameters among DPP4 inhibitor users and other oral hypoglycaemic drug users: a cross-sectional study from Anuradhapura, Sri Lanka
by: Devarajan Rathish, et al.
Published: (2019-01-01) -
Elevated Pancreatic Enzymes in ICU Patients With COVID-19 in Wuhan, China: A Retrospective Study
by: Peili Ding, et al.
Published: (2021-08-01) -
Effect of drinking high fluoride water on liver enzymes a comparitive cross-sectional study
by: Iftekhar Ahmed, et al.
Published: (2021-05-01) -
Assessment of liver function in COVID-19
by: Dipti Basavaraj Sanakal, et al.
Published: (2023-01-01)